Is Samsrita Labs a good stock to invest in?

Samsrita Labs can be analyzed on the following key metrics - TTM P/E: - Sector P/E: 0 Dividend Yield: 0% D/E ratio: -

Samsrita Labs Share Price

Sector: Healthcare Facilities

Powered by

20.71 -0.42 (-1.99%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 20.71

Today’s High 20.71

52 Week Low 12.19

52 Week High 32.36

Key Metrics

Market Cap (In Cr) 30.67
Beta 0.46
Div. Yield (%) 0
P/B 2.54
TTM P/E -
Sector P/E 0
D/E 0
Open Price 20.71
Prev Close 21.13

View All Metrics

Samsrita Labs Analysis

Price Analysis

1 Week

-3.94%
3 Months

47.93%
6 Month

-12.47%
YTD

-10.69%
1 Year

23.79%

Risk Meter

56% Low risk
56% Moderate risk
56% Balanced Risk
56% High risk
56% Extreme risk

Samsrita Labs Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.13

Depreciation/ Amortization
0

Other Operating Expenses Total
0.13

Total Operating Expense
0.26

Operating Income
-0.26

Net Income Before Taxes
-0.26

Net Income
-0.26

Diluted Normalized EPS
-0.18

Period
2024

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.13

Depreciation/ Amortization
0

Other Operating Expenses Total
0.12

Total Operating Expense
0.25

Operating Income
-0.25

Net Income Before Taxes
-0.25

Net Income
-0.25

Diluted Normalized EPS
-0.17

Period
2023

Total Revenue
0.02

Selling/ General/ Admin Expenses Total
0.13

Depreciation/ Amortization
0

Other Operating Expenses Total
0.86

Total Operating Expense
1.01

Operating Income
-0.99

Net Income Before Taxes
-0.71

Net Income
-0.71

Diluted Normalized EPS
-0.48

Period
2022

Total Revenue
0.02

Selling/ General/ Admin Expenses Total
0.11

Depreciation/ Amortization
0.01

Other Operating Expenses Total
0.16

Total Operating Expense
0.43

Operating Income
-0.41

Net Income Before Taxes
1.5

Net Income
1.5

Diluted Normalized EPS
1.01

Period
2021

Total Revenue
0.01

Selling/ General/ Admin Expenses Total
0.33

Depreciation/ Amortization
0.01

Other Operating Expenses Total
0.59

Total Operating Expense
0.93

Operating Income
-0.92

Net Income Before Taxes
-0.77

Net Income
-0.77

Diluted Normalized EPS
-0.52

Period
2020

Total Revenue
1.43

Selling/ General/ Admin Expenses Total
1.4

Depreciation/ Amortization
0.02

Other Operating Expenses Total
2

Total Operating Expense
3.64

Operating Income
-2.21

Net Income Before Taxes
-2.05

Net Income
-1.98

Diluted Normalized EPS
-1.36

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Samsrita Labs Technical

Moving Average SMA

5 Day21.39
10 Day22.11
20 Day21.71

50 Day20.89
100 Day19.79
300 Day21.16

Samsrita Labs Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Medinova Diagnostic Services
39.9
0.2
0.5
51.05
32.1
39.83

Tejnaksh Healthcare
19.2
0.27
1.43
29.5
18.79
39

Samsrita Labs
20.71
-0.42
-1.99
32.36
12.19
30.67

Global Longlife Hospital Researc
24.25
-0.69
-2.77
46.44
18.3
25.47

Chennai Meenakshi Multi Hospital
34
0.9
2.72
59.9
28.34
25.47

Samsrita Labs Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

30-Apr-25
Preferential issue of shares

26-Apr-25
Audited Results

08-Mar-25
Others

06-Jan-25
Quarterly Results

11-Nov-24
Quarterly Results

12-Aug-24
Quarterly Results

28-May-24
Audited Results

25-May-24
Audited Results

31-Jan-24
Quarterly Results

14-Nov-23
Quarterly Results

Meeting Date
Announced on
Purpose

23-May-25
02-May-25
EGM

21-Sept-24
12-Aug-24
AGM

31-Oct-23
06-Oct-23
EGM

28-Sept-23
05-Sept-23
AGM

15-Sept-21
11-Aug-21
AGM

View All

Company Profile

ABOUT Samsrita Labs

Industry Healthcare Facilities
ISIN INE579N01018
BSE Code 539267

Samsrita Labs Limited is an India-based biopharma company. The Company is engaged in activities, such as trading, exports and imports, manufacturing of bulk drugs, research, and development (R&D) through joint ventures or associations or mergers or by its own. It has established platforms in the areas of stem cell research and therapy, new drug discovery, molecular prognosis and diagnostics services, CRO, stem cell focused super specialty hospital, RNA interference technology, and medical devices. Its Stem Cell R&D division specializes in stem cell research and therapy, regenerative medicine, bio-artificial organ scaffolds development, nanobiotechnology, nanoformulation of cancer drugs, molecular genetics and molecular virology, stem cell, and cord blood banking. Its Molecular Prognosis and Diagnostics services division provides molecular diagnostics and services in the areas of cytogenetics, pharmacogenomics, pathology, radiology, hematology, biochemistry, and microbiology.

MANAGEMENT

Kalidindi Raju Executive Chairman of the Board, Compliance Officer
K. N. V. Kumar Chief Financial Officer, Executive Director

SAMSRITA LABS SUMMARY

Samsrita Labs is trading 1.99% lower at Rs 20.71 as compared to its last closing price. Samsrita Labs has been trading in the price range of 20.71 & 20.71. Samsrita Labs has given -10.69% in this year & -3.94% in the last 5 days.

The company posted a net profit of -0.09 Crores in its last quarter.

Listed peers of Samsrita Labs include Medinova Diagnostic Services (0.5%), Tejnaksh Healthcare (1.43%), Samsrita Labs (-1.99%) etc.

Samsrita Labs has a 49.27% promoter holding & 50.73% public holding.

FAQs about Samsrita Labs

Samsrita Labs is trading at 20.71 as on 27 Jun, 2025 3:15:00 PM. This is -1.99% lower as compared to its previous closing price of 21.13

The market capitalization of Samsrita Labs is 30.67 Cr as on 27 Jun, 2025 3:15:00 PM.

The 52 wk high for Samsrita Labs is 32.36 whereas the 52 wk low is 12.19

Samsrita Labs can be analyzed on the following key metrics -

TTM P/E: -
Sector P/E: 0
Dividend Yield: 0%
D/E ratio: -

Samsrita Labs reported a net profit of -0.26 Cr in 2025.

Samsrita Labs Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Samsrita Labs Share Price

Price Range

Key Metrics

Samsrita Labs Analysis

Samsrita Labs Financials

Forecast

Forecast

Forecast

Samsrita Labs Technical

Samsrita Labs Peers

Samsrita Labs Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Samsrita Labs

MANAGEMENT

SAMSRITA LABS SUMMARY

FAQs about Samsrita Labs

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue